サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1435017

バイオフィルム対策創傷被覆材市場：バイオフィルムタイプ、被覆材タイプ、流通チャネル、最終用途別-2024-2030年の世界予測

Anti-biofilm Wound Dressing Market by Biofilm Type (Bacterial Biofilm, Fungal Biofilm), Dressing Type (Alginate Dressings, Foam Dressings, Hydrocolloid Dressings), Distribution Channel, End-Use - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオフィルム対策創傷被覆材市場：バイオフィルムタイプ、被覆材タイプ、流通チャネル、最終用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオフィルム対策創傷被覆材市場規模は2023年に8億1,187万米ドルと推定され、2024年には8億7,224万米ドルに達し、CAGR 8.94%で2030年には14億7,853万米ドルに達すると予測されます。

バイオフィルム対策創傷被覆材の世界市場

主な市場の統計
基準年[2023］ 8億1,187万米ドル
予測年 [2024] 8億7,224万米ドル
予測年 [2030] 14億7,853万米ドル
CAGR（%） 8.94%
バイオフィルム対策創傷被覆材 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはバイオフィルム対策創傷被覆材市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、バイオフィルム対策創傷被覆材市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-バイオフィルム対策創傷被覆材市場の市場規模および予測は？

2-バイオフィルム対策創傷被覆材市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-バイオフィルム対策創傷被覆材市場における技術動向と規制の枠組みは？

4-バイオフィルム対策創傷被覆材市場における主要ベンダーの市場シェアは？

5-バイオフィルム対策創傷被覆材市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性および急性創傷の急増
      • 外来手術センターの増加
      • 交通事故や火傷の増加
    • 抑制要因
      • 急性創傷管理に伴う高額な治療費
    • 機会
      • 創傷バイオフィルムの感知と治療の進歩
      • 慢性創傷感染症の予防と治療における新たなイノベーション
    • 課題
      • 代替の高度な創傷治療用包帯の入手可能性
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 バイオフィルム対策創傷被覆材市場バイオフィルムの種類別

  • 細菌バイオフィルム
  • 真菌バイオフィルム

第7章 バイオフィルム対策創傷被覆材市場ドレッシングタイプ別

  • アルギン酸塩ドレッシング
  • 泡ドレッシング
  • ハイドロコロイド包帯
  • ヒドロゲル包帯
  • シリコンドレッシング

第8章 バイオフィルム対策創傷被覆材市場：流通チャネル別

  • オフライン
  • オンライン

第9章 バイオフィルム対策創傷被覆材市場：最終用途別

  • 在宅介護施設
  • 病院とクリニック

第10章 南北アメリカのバイオフィルム対策創傷被覆材市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のバイオフィルム対策創傷被覆材市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのバイオフィルム対策創傷被覆材市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 3M Company
    • Axio Biosolutions Pvt Ltd.
    • B. Braun SE
    • Coloplast Corp.
    • Convatec Inc.
    • Covalon Technologies Ltd.
    • Hollister Inc.
    • Imbed Biosciences
    • Integra LifeSciences
    • Lohmann & Rauscher
    • Medline Industries, LP
    • Mil Laboratories Pvt Ltd.
    • MIMEDX Group, Inc.
    • Molnlycke Health Care AB
    • Smith+Nephew PLC
    • URGO Group
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANTI-BIOFILM WOUND DRESSING MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTI-BIOFILM WOUND DRESSING MARKET DYNAMICS
  • FIGURE 7. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ANTI-BIOFILM WOUND DRESSING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ANTI-BIOFILM WOUND DRESSING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTI-BIOFILM WOUND DRESSING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BACTERIAL BIOFILM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY FUNGAL BIOFILM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY ALGINATE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY FOAM DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY HYDROCOLLOID DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY HYDROGEL DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY SILICONE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY HOMECARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY BIOFILM TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DRESSING TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ANTI-BIOFILM WOUND DRESSING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. ANTI-BIOFILM WOUND DRESSING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. ANTI-BIOFILM WOUND DRESSING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. ANTI-BIOFILM WOUND DRESSING MARKET LICENSE & PRICING
目次
Product Code: MRR-B168537776C8

[189 Pages Report] The Anti-biofilm Wound Dressing Market size was estimated at USD 811.87 million in 2023 and expected to reach USD 872.24 million in 2024, at a CAGR 8.94% to reach USD 1,478.53 million by 2030.

Global Anti-biofilm Wound Dressing Market

KEY MARKET STATISTICS
Base Year [2023] USD 811.87 million
Estimated Year [2024] USD 872.24 million
Forecast Year [2030] USD 1,478.53 million
CAGR (%) 8.94%
Anti-biofilm Wound Dressing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anti-biofilm Wound Dressing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anti-biofilm Wound Dressing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anti-biofilm Wound Dressing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Axio Biosolutions Pvt Ltd., B. Braun SE, Coloplast Corp., Convatec Inc., Covalon Technologies Ltd., Hollister Inc., Imbed Biosciences, Integra LifeSciences, Lohmann & Rauscher, Medline Industries, LP, Mil Laboratories Pvt Ltd., MIMEDX Group, Inc., Molnlycke Health Care AB, Smith+Nephew PLC, and URGO Group.

Market Segmentation & Coverage

This research report categorizes the Anti-biofilm Wound Dressing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Biofilm Type
    • Bacterial Biofilm
    • Fungal Biofilm
  • Dressing Type
    • Alginate Dressings
    • Foam Dressings
    • Hydrocolloid Dressings
    • Hydrogel Dressings
    • Silicone Dressings
  • Distribution Channel
    • Offline
    • Online
  • End-Use
    • Homecare Facilities
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anti-biofilm Wound Dressing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anti-biofilm Wound Dressing Market?

3. What are the technology trends and regulatory frameworks in the Anti-biofilm Wound Dressing Market?

4. What is the market share of the leading vendors in the Anti-biofilm Wound Dressing Market?

5. Which modes and strategic moves are suitable for entering the Anti-biofilm Wound Dressing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anti-biofilm Wound Dressing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surging prevalence of chronic and acute wounds
      • 5.1.1.2. Increasing number of ambulatory surgery centers
      • 5.1.1.3. Rising number of road accidents and burn injuries
    • 5.1.2. Restraints
      • 5.1.2.1. Associated high treatment cost for acute wound management
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in the sensing and treatment of wound biofilms
      • 5.1.3.2. Emerging innovations in the prevention & treatment of chronic wound infections
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative advanced wound care dressings
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anti-biofilm Wound Dressing Market, by Biofilm Type

  • 6.1. Introduction
  • 6.2. Bacterial Biofilm
  • 6.3. Fungal Biofilm

7. Anti-biofilm Wound Dressing Market, by Dressing Type

  • 7.1. Introduction
  • 7.2. Alginate Dressings
  • 7.3. Foam Dressings
  • 7.4. Hydrocolloid Dressings
  • 7.5. Hydrogel Dressings
  • 7.6. Silicone Dressings

8. Anti-biofilm Wound Dressing Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Anti-biofilm Wound Dressing Market, by End-Use

  • 9.1. Introduction
  • 9.2. Homecare Facilities
  • 9.3. Hospitals & Clinics

10. Americas Anti-biofilm Wound Dressing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anti-biofilm Wound Dressing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anti-biofilm Wound Dressing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. 3M Company
    • 14.1.2. Axio Biosolutions Pvt Ltd.
    • 14.1.3. B. Braun SE
    • 14.1.4. Coloplast Corp.
    • 14.1.5. Convatec Inc.
    • 14.1.6. Covalon Technologies Ltd.
    • 14.1.7. Hollister Inc.
    • 14.1.8. Imbed Biosciences
    • 14.1.9. Integra LifeSciences
    • 14.1.10. Lohmann & Rauscher
    • 14.1.11. Medline Industries, LP
    • 14.1.12. Mil Laboratories Pvt Ltd.
    • 14.1.13. MIMEDX Group, Inc.
    • 14.1.14. Molnlycke Health Care AB
    • 14.1.15. Smith+Nephew PLC
    • 14.1.16. URGO Group
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing